Insiders / Agarwal Shefali
Agarwal Shefali
CIK 1746830personinsider
Companies
3
First seen
Jan 27, 2021
Last activity
Jun 15, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Fate Therapeutics Inc · FATE | 10,490 | — |
| Epizyme, Inc. · EPZM | 0 | — |
| Gritstone Oncology, Inc. · GRTS | — | — |
All securities held
2 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Fate Therapeutics Inc | Common stock | 10,490 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Fate Therapeutics Inc | Options | 87,900 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Aug 9, 2022 | Exercise Option exercise | EPZM Epizyme, Inc. Common Stock, par value $0.0001 | $556.0K | +400K +154.61% | 658,716 | low |
| Aug 9, 2022 | Other Withheld for taxes | EPZM Epizyme, Inc. Common Stock, par value $0.0001 | $518.7K | -373K -56.65% | 285,562 | low |
| Aug 9, 2022 | Exercise Option exercise | EPZM Epizyme, Inc. Common Stock, par value $0.0001 | $78.6K |